InformedDNA to acquire Coriell Life Sciences.

InformedDNA, a precision health company, agreed to acquire Coriell Life Sciences, a provider of pharmacogenomic services. Financial terms were not disclosed. “The combination of our companies is a transformative step forward in the future of precision medicine. By uniting our expertise in pharmacogenomics and clinical decision support with InformedDNA’s industry-leading genetic test interpretation and counseling services, we are creating an unparalleled resource for patients, providers, and health organizations. Already, through our new DNAimpact platform, we are expanding access to a broader range of genetic insights and helping individuals and healthcare teams make more personalized, data-driven decisions. This partnership ensures that more people than ever before can benefit from the life-changing potential of genetics,” Scott Megill, Coriell Life Sciences CEO.